Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies
J Clin Invest
.
2019 Feb 1;129(2):489-491.
doi: 10.1172/JCI126044.
Epub 2019 Jan 7.
Authors
Mark W Dewhirst
1
,
Yvonne M Mowery
1
,
James B Mitchell
2
,
Murali K Cherukuri
2
,
Timothy W Secomb
3
Affiliations
1
Radiation Oncology Department, Duke University Medical School, Durham, North Carolina, USA.
2
Radiation Biology Branch, National Cancer Institute, Bethesda, Maryland, USA.
3
Department of Physiology, University of Arizona College of Medicine, Tucson, Arizona, USA.
PMID:
30614815
PMCID:
PMC6355230
DOI:
10.1172/JCI126044
No abstract available
Publication types
Review
MeSH terms
Animals
Humans
Hypoxia*
Immunologic Memory*
Immunotherapy*
Neoplasms* / immunology
Neoplasms* / pathology
Neoplasms* / therapy
Precision Medicine*